What payers require for Mounjaro prior authorization For Mounjaro (diabetes indication), most payers require: Confirmed type 2 diabetes diagnosis with recent HbA1c level (typically above 7.0%) Documentation of current diabetes medications and their inadequacy (most plans require failure of metformin unless contraindicated) Step therapy documentation showing the patient has tried first-line agents before progressing to tirzepatide Prescriber specialty (some plans restrict initial prescribing to endocrinologists or require specialist consultation) The PA request uses the tirzepatide dosing schedule as part of the clinical rationale
PRP for jumper's knee: exploring healing acceleration and outcome improvement In this literature review, several studies have explored the effectiveness of PRP as a treatment option for patellar tendinopathy, with mixed results [19,20,21,22,23,24,25,26,27,28,29,30,31,32,33]
BPC-157 also has a strong gastrointestinal foundation
So we're getting into it with health reporter Sarah Boden, who's covered this topic for NPR